EU Decision Time On Broader Indication For AbbVie’s Skyrizi
Verdict Also Due On Expanding Olumiant’s Use As COVID-19 Treatment
The European Medicines Agency is meeting this week to consider applications to broaden the use of approved drugs to include new indications in the EU.
